Hologic did an all cash offer, 25% premium for Thirdwave, both boards approved. This was shortly after Thirdwave submitted an NDA for their hpv tests. So we're close, but not quite there yet. That said, the twist with Exact, is the market potential. With 1 Billion in revenue at stake, it's a large risk for a potential acquirer to sit on the sidelines and wait. I think a deal gets done ahead of Deep-C results.